Galactosidase
From Proteopedia
(Difference between revisions)
(38 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | + | <StructureSection load='3w5g' size='350' side='right' caption='Glycosylated beta-galactosidase complex with galactose (PDB entry [[3w5g]])' scene=''> | |
- | + | == Function == | |
+ | '''α-Galactosidase''' (Agal) hydrolyzes the terminal α-galactosyl moiety from glycoproteins and glycolipids<ref>PMID:15003450</ref>. | ||
+ | *'''β-Galactosidase''' (Bgal) hydrolyzes β-galactosides into monosaccharides<ref>PMID:8008071</ref>. | ||
+ | Isopropyl-β-d-thiogalactopyranoside (IPTG) induces Bgal activity. Phenylethyl-β-d-thiogalactopyranoside (PETG) is an inhibitor. Galactose, lactose, o-nitrophenyl-β-d-galactoside (ONPG) are substrates. Galactopyranosyl is reaction intermediate.<br /> For details on α-galactosidase see [[Garman lab: Interconversion of lysosomal enzyme specificities]].<br />For details on β-galactosidase see [[Molecular Playground/Beta-galactosidase]]. | ||
+ | See also: [[Beta-galactosidase (hebrew)]] | ||
+ | *'''Endo-1,4-β-galactosidase''' hydrolyzes pectic galactans to produce D-galactose, beta-1,4-D galactobiose, beta-1,4-D galactotriose and beta-1,4-D galactotetraose<ref>PMID:16495677</ref>. | ||
+ | See also [[Lactase (a protein)]] | ||
+ | == Relevance == | ||
+ | Bgal assay is used in molecular biology to monitor gene expression. | ||
+ | == Disease == | ||
+ | The inherited deficiency of Agal is the cause of Fabry disease<ref>PMID:5411915</ref>. Bgal mutations causing enzyme deficiency can lead to ganglioidosis<ref>PMID:10737981</ref>. | ||
+ | == Structural highlights == | ||
+ | The <scene name='45/458439/Cv/3'>Zn+2 binding site is composed of 4 Cys residues</scene>. The <scene name='45/458439/Cv/5'>galactose binding site</scene> is seen in a <scene name='45/458439/Cv/6'>large central channel</scene><ref>PMID:12215416</ref>. Water molecules shown as red spheres. | ||
- | + | For [[3hg2]] <scene name='3hg2/3hg2to3morph/6'>click here to see cycling morph from empty active site to substrate bound form and back</scene>.<br /> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
== 3D Structures of Galactosidase == | == 3D Structures of Galactosidase == | ||
+ | [[Galactosidase 3D structures]] | ||
- | + | </StructureSection> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | == References == | ||
+ | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
<br /> | <br /> | ||
*Created with the participation of [[User:Wayne Decatur|Wayne Decatur]]. | *Created with the participation of [[User:Wayne Decatur|Wayne Decatur]]. |
Current revision
|
References
- ↑ Garman SC, Garboczi DN. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol. 2004 Mar 19;337(2):319-35. PMID:15003450 doi:10.1016/j.jmb.2004.01.035
- ↑ Jacobson RH, Zhang XJ, DuBose RF, Matthews BW. Three-dimensional structure of beta-galactosidase from E. coli. Nature. 1994 Jun 30;369(6483):761-6. PMID:8008071 doi:http://dx.doi.org/10.1038/369761a08015589
- ↑ Yang H, Ichinose H, Yoshida M, Nakajima M, Kobayashi H, Kaneko S. Characterization of a thermostable endo-beta-1,4-D-galactanase from the hyperthermophile Thermotoga maritima. Biosci Biotechnol Biochem. 2006 Feb;70(2):538-41. PMID:16495677 doi:10.1271/bbb.70.538
- ↑ Kint JA. Fabry's disease: alpha-galactosidase deficiency. Science. 1970 Feb 27;167(3922):1268-9. PMID:5411915
- ↑ Morrone A, Bardelli T, Donati MA, Giorgi M, Di Rocco M, Gatti R, Parini R, Ricci R, Taddeucci G, D'Azzo A, Zammarchi E. beta-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. Hum Mutat. 2000;15(4):354-66. PMID:10737981 doi:<354::AID-HUMU8>3.0.CO;2-L 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.0.CO;2-L
- ↑ Hidaka M, Fushinobu S, Ohtsu N, Motoshima H, Matsuzawa H, Shoun H, Wakagi T. Trimeric crystal structure of the glycoside hydrolase family 42 beta-galactosidase from Thermus thermophilus A4 and the structure of its complex with galactose. J Mol Biol. 2002 Sep 6;322(1):79-91. PMID:12215416
- Created with the participation of Wayne Decatur.